Thrombosis and infection are the leading causes of blood-contacting device (BCD) failure, mainly due to the poor performance of existing biomaterials. Poly(2-hydroxyethyl methacrylate) (pHEMA) has excellent hemocompatibility but the weak mechanical properties impair its use as a bulk material for BCD. As such, pHEMA has been explored as a coating, despite the instability and difficulty of attachment to the underlying polymer compromise its success. This work describes the hydrogel composites made of pHEMA and graphene-based materials (GBM) that meet the biological and mechanical requirements for a stand-alone BCD. Five GBM differing in thickness, oxidation degree, and lateral size were incorporated in pHEMA, revealing that only oxidized-GBM can reinforce pHEMA. pHEMA/oxidized-GBM composites are cytocompatible and prevent the adhesion of endothelial cells, blood platelets, and bacteria (S. aureus), thus maintaining pHEMA's anti-adhesive properties. As a proof of concept, the thrombogenicity of the tubular prototypes of the best formulation (pHEMA/Graphene oxide (GO)) was evaluated in vivo, using a porcine arteriovenous-shunt model. pHEMA/GO conduits withstand the blood pressure and exhibit negligible adhesion of blood components, revealing better hemocompatibility than ePTFE, a commercial material for vascular access. Our findings reveal pHEMA/GO, a synthetic and off-the-shelf hydrogel, as a preeminent material for the design of blood-contacting devices that prevent thrombosis and bacterial adhesion.
Blood-contacting devices are increasingly important for the management of cardiovascular diseases. Poly(ethylene glycol) (PEG) hydrogels represent one of the most explored hydrogels to date. However, they are mechanically weak, which prevents their use in load-bearing biomedical applications (e.g., vascular grafts, cardiac valves). Graphene and its derivatives, which have outstanding mechanical properties, a very high specific surface area, and good compatibility with many polymer matrices, are promising candidates to solve this challenge. In this work, we propose the use of graphene-based materials as nanofillers for mechanical reinforcement of PEG hydrogels, and we obtain composites that are stiffer and stronger than, and as anti-adhesive as, neat PEG hydrogels. Results show that single-layer and few-layer graphene oxide can strengthen PEG hydrogels, increasing their stiffness up to 6-fold and their strength 14-fold upon incorporation of 4% w/v (40 mg/mL) graphene oxide. The composites are cytocompatible and remain anti-adhesive towards endothelial cells, human platelets and Staphylococcus aureus, similar to neat hydrogels. To the best of our knowledge, this is the first work to report such an increase of the tensile properties of PEG hydrogels using graphene-based materials as fillers. This work paves the way for the exploitation of PEG hydrogels as a backbone material for load-bearing applications.
The incorporation of graphene‐based materials into hydrogels enhances their mechanical, electroconductive, and antimicrobial properties, offering significant potential for biomedical applications. However, 3D printing graphene‐containing inks may present challenges because of their unsuitable shape retention or the fact that the concentration of the graphene component can hinder photocrosslinking. This study explores embedded 3D printing to process a chemically crosslinkable poly(ethylene glycol) ink with a high (4% w/v) graphene oxide concentration (PEG/GO). Given the PEG/GO ink's insufficient shape retention and slow crosslinking, various support baths are screened, with the microparticulate bath of the crystal self‐healing embedding bioprinting (CLADDING) method proving most effective. The interstitial solution of the CLADDING bath influences the mechanical properties of printed PEG/GO constructs. Multilayered PEG/GO cylindrical constructs with <500 μm filament width and up to 4.5 mm height (30 layers) are fabricated, presenting better tensile properties when printed within CLADDING in calcium chloride (vs. baths in crosslinking initiators). The surface of PEG/GO constructs is anti‐adhesive toward human foreskin fibroblasts, and their extracts are cytocompatible. Hence, embedded 3D printing emerges as an innovative strategy to surpass limitations of shaping graphene‐containing hydrogels into complex geometries, broadening the biomanufacturing possibilities for diverse biomedical applications requiring kPa‐range mechanical properties.